Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Combined burden and functional impact tests for cancer driver discovery using DriverPower

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Genomic footprints of activated telomere maintenance mechanisms in cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Pathway and network analysis of more than 2500 whole cancer genomes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Prenatal dietary supplements influence the infant airway microbiota in a randomized factorial clinical trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Reply to: Clinical impact of high platelet count and high hematocrit, by Marc Sorigue

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Obesity as a Causal Risk Factor for Aortic Valve Stenosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Lipoprotein(a) Reduction in Persons with Cardiovascular Disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Viktoria Gusarova
  • Colm O'Dushlaine
  • Tanya M. Teslovich
  • Peter N. Benotti
  • Tooraj Mirshahi
  • Omri Gottesman
  • Cristopher V. Van Hout
  • Michael F. Murray
  • Anubha Mahajan
  • Jonas B. Nielsen
  • Lars Fritsche
  • Anders Berg Wulff
  • Daniel F. Gudbjartsson
  • Marketa Sjögren
  • Connor A. Emdin
  • Robert A. Scott
  • Wen Jane Lee
  • Aeron Small
  • Lydia C. Kwee
  • Om Prakash Dwivedi
  • Rashmi B. Prasad
  • Shannon Bruse
  • Alexander E. Lopez
  • John Penn
  • Anthony Marcketta
  • Joseph B. Leader
  • Christopher D. Still
  • H. Lester Kirchner
  • Uyenlinh L. Mirshahi
  • Amr H. Wardeh
  • Cassandra M. Hartle
  • Lukas Habegger
  • Samantha N. Fetterolf
  • Teresa Tusie-Luna
  • Andrew P. Morris
  • Hilma Holm
  • Valgerdur Steinthorsdottir
  • Patrick Sulem
  • Unnur Thorsteinsdottir
  • Jerome I. Rotter
  • Lee Ming Chuang
  • Scott Damrauer
  • David Birtwell
  • Chad M. Brummett
  • Amit V. Khera
  • Pradeep Natarajan
  • Marju Orho-Melander
  • Jason Flannick
  • Luca A. Lotta
  • Cristen J. Willer
  • Oddgeir L. Holmen
  • Marylyn D. Ritchie
  • David H. Ledbetter
  • Andrew J. Murphy
  • Ingrid B. Borecki
  • Jeffrey G. Reid
  • John D. Overton
  • Ola Hansson
  • Leif Groop
  • Svati H. Shah
  • William E. Kraus
  • Daniel J. Rader
  • Yii Der I. Chen
  • Kristian Hveem
  • Nicholas J. Wareham
  • Sekar Kathiresan
  • Olle Melander
  • Kari Stefansson
  • Børge G. Nordestgaard
  • Anne Tybjærg-Hansen
  • Goncalo R. Abecasis
  • David Altshuler
  • Jose C. Florez
  • Michael Boehnke
  • Mark I. McCarthy
  • George D. Yancopoulos
  • David J. Carey
  • Alan R. Shuldiner
  • Aris Baras
  • Frederick E. Dewey
  • Jesper Gromada
Vis graf over relationer

Angiopoietin-like 4 (ANGPTL4) is an endogenous inhibitor of lipoprotein lipase that modulates lipid levels, coronary atherosclerosis risk, and nutrient partitioning. We hypothesize that loss of ANGPTL4 function might improve glucose homeostasis and decrease risk of type 2 diabetes (T2D). We investigate protein-altering variants in ANGPTL4 among 58,124 participants in the DiscovEHR human genetics study, with follow-up studies in 82,766 T2D cases and 498,761 controls. Carriers of p.E40K, a variant that abolishes ANGPTL4 ability to inhibit lipoprotein lipase, have lower odds of T2D (odds ratio 0.89, 95% confidence interval 0.85-0.92, p = 6.3 × 10-10), lower fasting glucose, and greater insulin sensitivity. Predicted loss-of-function variants are associated with lower odds of T2D among 32,015 cases and 84,006 controls (odds ratio 0.71, 95% confidence interval 0.49-0.99, p = 0.041). Functional studies in Angptl4-deficient mice confirm improved insulin sensitivity and glucose homeostasis. In conclusion, genetic inactivation of ANGPTL4 is associated with improved glucose homeostasis and reduced risk of T2D.

OriginalsprogEngelsk
Artikelnummer2252
TidsskriftNature Communications
Vol/bind9
Udgave nummer1
Sider (fra-til)2252
ISSN2041-1723
DOI
StatusUdgivet - 1 dec. 2018

ID: 55678524